[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
FW: Morgan Stanley on the STM Publishing market
- To: "Liblicense-L (E-mail)" <liblicense-l@lists.yale.edu>
- Subject: FW: Morgan Stanley on the STM Publishing market
- From: "Hamaker, Chuck" <cahamake@email.uncc.edu>
- Date: Wed, 4 Dec 2002 19:07:00 EST
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
For those who have access to Gale's Investext the full report is available under the title: Scientific Publishing: Knowledge is Power. Chris Beckett's article in UKSG newsletter On Morgan Stanley's Sept. 2002 report: Scientific Publishing: Knowledge is Power. Re: Morgan Stanley on the STM Publishing market see: http://www.biblio-tech.com/uksg/SI_PD.cfm?PID=10&ArticleID=469 the niche nature of the market, and the rapid growth in the budgets of academic libraries have combined to make scientific publishing the fastest growing sub-sector of the media industry over the past 15 years, according to the report. specific points in the report of interest to librarians; Scientific journals have been the fastest growing media sub-sector of the past 15 years, and the level of organic revenue growth is such that it prompted the Office of Fair Trading to conclude that the journals market may not be working too well. That journal publishers are likely to moderate price increases while improving the value proposition through electronic delivery. That pressure on library budgets will result in industry growth slowing from 8% in 2001 to 3% in 2002. That the market leader Reed Elsevier will outperform the market as libraries trim peripheral suppliers who cannot bundle their journals as effectively. That margins will expand for journal publishers as users move to online access. Libraries will benefit from accessing journals solely on-line, as operating costs are currently $1.50 for every $1.00 of content spend. Publishers will benefit, as the profitability of on-line only customers will translate to a 16% improvement in profitability of those customers. That Reed Elsevier will be a key beneficiary of that trend.
- Prev by Date: INIST/BioMed Central Partnership
- Next by Date: Re: NGO immunity from prosecution
- Prev by thread: RE: Shrinkwrap contract on books
- Next by thread: INIST/BioMed Central Partnership
- Index(es):